Request Discount

4060

Order Summary

Report Title

T-cell Therapy Market By Type (CAR T-cell Therapy; Tumor Infiltrating Lymphocytes (TIL)-based; T Cell Receptor (TCR)-based); By Indication (Hematologic Malignancies (Leukemia; Lymphoma; Myeloma); Solid Tumors (Melanoma; Brain & Central Nervous System; Liver Cancer; Others); Others); By End-User (Hospitals; Cancer Treatment Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Report Id	22353731
License Type
Price	USD
Total	USD

Buy Now